Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran

Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran Publisher Pubmed

Hadji M^{1, 2} ; Rashidian H² ; Marzban M^{3, 4} ; Naghibzadehtahami A^{5, 6} ; Gholipour M⁷ ; Mohebbi E^{2, 8} ; Safarifaramani R⁹ ; Seyyedsalehi MS² ; Hosseini B^{2, 10} ; Bakhshi M¹¹ ; Alizadehnavaei R¹² ; Ahmadi L¹³ ; Rezaianzadeh A¹³ ; Moradi A¹⁴ Show All Authors

Hadji M^{1, 2}
Rashidian H²
Marzban M^{3, 4}
Naghibzadehtahami A^{5, 6}
Gholipour M⁷
Mohebbi E^{2, 8}
Safarifaramani R⁹
Seyyedsalehi MS²
Hosseini B^{2, 10}
Bakhshi M¹¹
Alizadehnavaei R¹²
Ahmadi L¹³
Rezaianzadeh A¹³
Moradi A¹⁴
Ansarimoghaddam A¹¹
Nejatizadeh A¹⁵
Shahidsales S¹⁶
Zohrabi F¹⁷
Mohammadi R^{18, 19}
Nowroozi MR²⁰
Poustchi H²¹
Nasrollahzadeh D¹⁰
Najafi F^{9, 22}
Haghdoost AA^{6, 23}
Rahimimovaghar A²⁴
Etemadi A^{25, 26}
Mohagheghi MA²
Malekzadeh R^{21, 25}
Brennan P¹⁰
Schuz J¹⁰
Boffetta P^{27, 28}
Weiderpass E¹⁰
Kamangar F²⁹
Zendehdel K²
Pukkala E^{1, 30}

Show Affiliations

1. Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland
2. Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Public Health, School of Public Health, Bushehr University of Medical Science, Bushehr, Iran
4. Clinical Research Development Center, Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr, Iran
5. Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
6. Department of Biostatistics and Epidemiology, Kerman University of Medical Sciences, Kerman, Iran
7. Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
8. Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
9. Research Center for Environmental Determinants of Health, School of Public Health, Kermanshah Medical Sciences University, Kermanshah, Iran
10. International Agency for Research on Cancer, Lyon, France
11. Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
12. Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
13. Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
14. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
15. Tobacco and Health Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
16. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
17. Department of Urology, School of Medicine, Busher University of Medical Science, Bushehr, Iran
18. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
19. Department of Urology, Kerman University of Medical Sciences, Kerman, Iran
20. Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
21. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
22. Social Development and Health Promotion Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
23. Regional Knowledge HUB for HIV/AIDS Surveillance, Research Centre for Modelling in Health, Institute for Future Studies in Health, Kerman, Iran
24. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
25. Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran, Iran
26. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States
27. Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, United States
28. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
29. Department of Biology, School of Computer, Natural Sciences, Baltimore, MD, United States
30. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland

Source: International Journal of Epidemiology Published:2022

Abstract

Background: Bladder cancer (BC) is the 10th most common type of cancer worldwide and the fourth most common type of cancer in Iran. Opium use is considered as one of the risk factors for BC. We aim to assess the association between various parameters of opium use, which in Iran is mainly ingested or smoked in various forms, and the risk of BC. Method: In this multi-centre case-referent study in Iran, 717 BC cases and 3477 referents were recruited to the study from May 2017 until July 2020. Detailed histories of opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure adjusted odds ratio (OR) and 95% confidence intervals (CI). The ORs were adjusted for age, gender, place of residence and pack-years of cigarette smoking. Results: Regular opium consumption was associated with an increased risk of BC (OR 3.5, 95% CI: 2.8, 4.3) compared with subjects who never used opium. Compared with continuous users, the risk decreased to one-Third for those who stopped opium more than 10 years ago. The adjusted OR for those who used both crude opium (teriak) and opium juice was 7.4 (95% CI: 4.1, 13.3). There was a joint effect of opium and tobacco (OR for users of both opium and tobacco 7.7, 95% CI: 6.0, 9.7). Conclusions: Regular opium use is associated with an approximately 4-fold risk for BC. The OR decreases along with the increasing time since stopping opium use. © 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the International Epidemiological Association.

Related Docs

View other Related Docs

1. The Carcinogenicity of Opium Consumption: A Systematic Review and Meta-Analysis, European Journal of Epidemiology (2023)

2. The Iranian Study of Opium and Cancer (Iropican): Rationale, Design, and Initial Findings, Archives of Iranian Medicine (2021)

3. Fifty Years of Research and One Conclusion: Opium Causes Cancer, Archives of Iranian Medicine (2020)

4. Opium Use and the Risk of Liver Cancer: A Case–Control Study, Cancer Prevention Research (2023)

5. Opium Use and Risk of Lung Cancer: A Multicenter Case-Control Study in Iran, International Journal of Cancer (2023)

6. Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer?, Archives of Iranian Medicine (2022)

7. Opium Use and Risk of Colorectal Cancer: A Multi-Center Case-Referent Study in Iran, Acta Oncologica (2023)

8. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)

Experts (# of related papers)

View all Related Experts

Reza Malekzadeh (26)

Kazem Zendehdel (19)

Style	Citing Format
MLA	Hadji M, et al.. "Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran." International Journal of Epidemiology, vol. 51, no. 3, 2022, pp. 830-838.
APA	Hadji M, Rashidian H, Marzban M, Naghibzadehtahami A, Gholipour M, Mohebbi E, Safarifaramani R, Seyyedsalehi MS, Hosseini B, Bakhshi M, Alizadehnavaei R, Ahmadi L, Rezaianzadeh A, Moradi A, Ansarimoghaddam A, Nejatizadeh A, Shahidsales S, Zohrabi F, Mohammadi R, ... Pukkala E (2022). Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran. International Journal of Epidemiology, 51(3), 830-838.
Chicago	Hadji M, Rashidian H, Marzban M, Naghibzadehtahami A, Gholipour M, Mohebbi E, Safarifaramani R, et al.. "Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran." International Journal of Epidemiology 51, no. 3 (2022): 830-838.
Harvard	Hadji M et al. (2022) 'Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran', International Journal of Epidemiology, 51(3), pp. 830-838.
Vancouver	Hadji M, Rashidian H, Marzban M, Naghibzadehtahami A, Gholipour M, Mohebbi E, et al.. Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran. International Journal of Epidemiology. 2022;51(3):830-838.
BibTex	@article{ author = {Hadji M and Rashidian H and Marzban M and Naghibzadehtahami A and Gholipour M and Mohebbi E and Safarifaramani R and Seyyedsalehi MS and Hosseini B and Bakhshi M and Alizadehnavaei R and Ahmadi L and Rezaianzadeh A and Moradi A and Ansarimoghaddam A and Nejatizadeh A and Shahidsales S and Zohrabi F and Mohammadi R and Nowroozi MR and Poustchi H and Nasrollahzadeh D and Najafi F and Haghdoost AA and Rahimimovaghar A and Etemadi A and Mohagheghi MA and Malekzadeh R and Brennan P and Schuz J and Boffetta P and Weiderpass E and Kamangar F and Zendehdel K and Pukkala E}, title = {Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran}, journal = {International Journal of Epidemiology}, volume = {51}, number = {3}, pages = {830-838}, year = {2022} }
RIS	TY - JOUR AU - Hadji M AU - Rashidian H AU - Marzban M AU - Naghibzadehtahami A AU - Gholipour M AU - Mohebbi E AU - Safarifaramani R AU - Seyyedsalehi MS AU - Hosseini B AU - Bakhshi M AU - Alizadehnavaei R AU - Ahmadi L AU - Rezaianzadeh A AU - Moradi A AU - Ansarimoghaddam A AU - Nejatizadeh A AU - Shahidsales S AU - Zohrabi F AU - Mohammadi R AU - Nowroozi MR AU - Poustchi H AU - Nasrollahzadeh D AU - Najafi F AU - Haghdoost AA AU - Rahimimovaghar A AU - Etemadi A AU - Mohagheghi MA AU - Malekzadeh R AU - Brennan P AU - Schuz J AU - Boffetta P AU - Weiderpass E AU - Kamangar F AU - Zendehdel K AU - Pukkala E TI - Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran JO - International Journal of Epidemiology VL - 51 IS - 3 SP - 830 EP - 838 PY - 2022 ER -

Style

Citing Format

MLA

Hadji M, et al.. "Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran." International Journal of Epidemiology, vol. 51, no. 3, 2022, pp. 830-838.

APA

Hadji M, Rashidian H, Marzban M, Naghibzadehtahami A, Gholipour M, Mohebbi E, Safarifaramani R, Seyyedsalehi MS, Hosseini B, Bakhshi M, Alizadehnavaei R, Ahmadi L, Rezaianzadeh A, Moradi A, Ansarimoghaddam A, Nejatizadeh A, Shahidsales S, Zohrabi F, Mohammadi R, ... Pukkala E (2022). Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran. International Journal of Epidemiology, 51(3), 830-838.

Chicago

Hadji M, Rashidian H, Marzban M, Naghibzadehtahami A, Gholipour M, Mohebbi E, Safarifaramani R, et al.. "Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran." International Journal of Epidemiology 51, no. 3 (2022): 830-838.

Harvard

Hadji M et al. (2022) 'Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran', International Journal of Epidemiology, 51(3), pp. 830-838.

Vancouver

Hadji M, Rashidian H, Marzban M, Naghibzadehtahami A, Gholipour M, Mohebbi E, et al.. Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran. International Journal of Epidemiology. 2022;51(3):830-838.

BibTex

@article{ author = {Hadji M and Rashidian H and Marzban M and Naghibzadehtahami A and Gholipour M and Mohebbi E and Safarifaramani R and Seyyedsalehi MS and Hosseini B and Bakhshi M and Alizadehnavaei R and Ahmadi L and Rezaianzadeh A and Moradi A and Ansarimoghaddam A and Nejatizadeh A and Shahidsales S and Zohrabi F and Mohammadi R and Nowroozi MR and Poustchi H and Nasrollahzadeh D and Najafi F and Haghdoost AA and Rahimimovaghar A and Etemadi A and Mohagheghi MA and Malekzadeh R and Brennan P and Schuz J and Boffetta P and Weiderpass E and Kamangar F and Zendehdel K and Pukkala E}, title = {Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran}, journal = {International Journal of Epidemiology}, volume = {51}, number = {3}, pages = {830-838}, year = {2022} }

RIS

TY - JOUR
AU - Hadji M
AU - Rashidian H
AU - Marzban M
AU - Naghibzadehtahami A
AU - Gholipour M
AU - Mohebbi E
AU - Safarifaramani R
AU - Seyyedsalehi MS
AU - Hosseini B
AU - Bakhshi M
AU - Alizadehnavaei R
AU - Ahmadi L
AU - Rezaianzadeh A
AU - Moradi A
AU - Ansarimoghaddam A
AU - Nejatizadeh A
AU - Shahidsales S
AU - Zohrabi F
AU - Mohammadi R
AU - Nowroozi MR
AU - Poustchi H
AU - Nasrollahzadeh D
AU - Najafi F
AU - Haghdoost AA
AU - Rahimimovaghar A
AU - Etemadi A
AU - Mohagheghi MA
AU - Malekzadeh R
AU - Brennan P
AU - Schuz J
AU - Boffetta P
AU - Weiderpass E
AU - Kamangar F
AU - Zendehdel K
AU - Pukkala E
TI - Opium Use and Risk of Bladder Cancer: A Multi-Centre Case-Referent Study in Iran
JO - International Journal of Epidemiology
VL - 51
IS - 3
SP - 830
EP - 838
PY - 2022
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract